Naproxen Tablet, Delayed Release
Product Images NDC 70954-925

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 70954-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-1 (Label 1)

This text is a description of Naproxen Delayed-Release Tablets, containing 375 mg naproxen per tablet. The packaging includes details on recommended dosage, storage instructions, and the importance of keeping the medication out of the reach of children. It is distributed by ANI Pharmaceuticals, Inc. and comes in a tamper-evident container.*

FDA Label Image

Label-2 (Label 2)

This is a description of Naproxen Delayed-Release Tablets, USP containing 500 mg of naproxen per tablet. The recommended dosage is to be referred to the prescribing information. It should be dispensed in light-resistant containers and stored at 20-25°C (68-77°F). The medication guide should be provided to each patient. It is distributed by ANI Pharmaceuticals, Inc., with a tamper-evident container. Keep out of reach of children.*

FDA Label Image

Structure (Naproxen)

This is a chemical description of Naproxen, which has a molecular weight of 230.26 g/mol and is represented by the chemical formula C14H14O3. The structure of naproxen includes a carboxylic acid functional group designated as (-COOH).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.